Human leukocyte antigen (HLA)-DRB1 allele polymorphisms and systemic sclerosis

References

• Bălănescu P, Lădaru A, Bălănescu E, Nicolau A, Băicuş C, Dan GA. IL-17, IL-6 and IFN-gamma in systemic sclerosis patients. Rom J Intern Med. 2015;53(1):46–9.
   Web of Science ®Google Scholar
• Chairta P, Nicolaou P, Christodoulou K. Genomic and genetic studies of systemic sclerosis: a systematic review. Hum Immunol. 2017;78(2):153–65.
   PubMed Web of Science ®Google Scholar
• Arif T, Masood Q, Singh J, Hassan I. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. BMC Gastroenterol. 2015;15(1):24.
   PubMed Web of Science ®Google Scholar
• Korman BD, Criswell LA. Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance. Curr Rheumatol Rep. 2015;17(3):21.
   PubMed Web of Science ®Google Scholar
• Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.
   PubMed Web of Science ®Google Scholar
• Song YW, Lee EB, Whang DH, Kang SJ, Takeuchi F, Park MH. Association of TAP1 and TAP2 gene polymorphisms with systemic sclerosis in Korean patients. Hum Immunol. 2005;66(7):810–17.
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang Y, Wang Q, Xiao R, Lu Q. Systemic sclerosis: genetics and epigenetics. J Autoimmun. 2013;41:161–7.
   PubMed Web of Science ®Google Scholar
• Azzouz DF, Rak JM, Fajardy I, Allanore Y, Tiev KP, Farge-Bancel D, et al. Comparing HLA shared epitopes in French Caucasian patients with scleroderma. PLoS One. 2012;7(5):e36870.
   PubMed Web of Science ®Google Scholar
• He D, Wang J, Yi L, Guo X, Guo S, Guo G, et al. Association of the HLA-DRB1 with scleroderma in Chinese population. PloS One. 2014;9(9):e106939.
   PubMed Web of Science ®Google Scholar
• Kang SH, Park MH, Song EY, Kang SJ, Lee EB, Song YW. Association of HLA class II genes with systemic sclerosis in Koreans. J Rheumatol. 2001;28(7):1577–83.
   PubMed Web of Science ®Google Scholar
• Dimitroulas T, Daoussis D, Garyfallos A, Sfikakis PP, Kitas GD. Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. CMC. 2015;22(16):1943.
   PubMed Web of Science ®Google Scholar
• Kowal-Bielecka O, Bielecki M, Kowal K. Recent advances in the diagnosis and treatment of systemic sclerosis. Pol Arch Med Wewn. 2013;123(1–2):51–8.
   PubMed Web of Science ®Google Scholar
• Johnson ME, Pioli PA, Whitfield ML. Gene expression profiling offers insights into the role of innate immune signaling in SSc. Semin Immunopathol. 2015;37(5):501.
   PubMed Web of Science ®Google Scholar
• Marie I, Gehanno JF. Environmental risk factors of systemic sclerosis. Semin Immunopathol. 2015;37(5):463–73.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P. HLA markers for susceptibility and expression in scleroderma. J Rheumatol. 2005;32(8):1481–7.
   PubMed Web of Science ®Google Scholar
• Kazuyoshi H, Takashi S, Atsushi T, Ituro I. The impact of next-generation sequencing technologies on HLA research. J Hum Genet. 2015;60(11):665–73.
   PubMed Web of Science ®Google Scholar
• Del Rio AP, Sachetto Z, Sampaio-Barros PD, Marques-Neto JF, Londe AC, Bertolo MB. HLA markers for poor prognosis in systemic sclerosis Brazilian patients. Dis Markers. 2013;35(2):73–8.
   PubMed Web of Science ®Google Scholar
• Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med. 2000;343(11):782–6.
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008;112(5):1557–69.
   PubMed Web of Science ®Google Scholar
• Furukawa H, Oka S, Tsuchiya N, Shimada K, Hashimoto A, Tohma S, et al. The role of common protective alleles HLA-DRB1|[ast]|13 among systemic autoimmune diseases. Genes Immun. 2017;18(1):1.
   PubMed Web of Science ®Google Scholar
• Tan FK, Stivers DN, Arnett FC, Chakraborty R, Howard R, Reveille JD. HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens. 1999;53(1):74–80.
   PubMedGoogle Scholar
• Loubière LS, Lambert NC, Madeleine MM, Porter AJ, Mullarkey ME, Pang JM, et al. HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women. Rheumatology (Oxford). 2005;44(3):318–22.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann Rheum Dis. 1995;54(12):983–7.
   PubMed Web of Science ®Google Scholar
• Fanning GC, Welsh KI, Bunn C, Bois RD, Black CM. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol. 1998;37(2):201.
   PubMedGoogle Scholar
• Van dHF, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–55.
   PubMed Web of Science ®Google Scholar
• Reveille JD, Fischbach M, Mcnearney T, Friedman AW, Aguilar MB, Lisse J. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum. 2001;30(5):332–46.
   PubMed Web of Science ®Google Scholar
• Stevens AM, Kanaan SB, Torok KS, Medsger TA, Mayes MD, Reveille JD, et al. Brief report: HLA-DRB1, DQA1, and DQB1 in juvenile-onset systemic sclerosis. Arthritis Rheumatol. 2016;68(11):2772–7.
   PubMed Web of Science ®Google Scholar
• Joung CI, Jun JB, Chung WT, Song GG, Choe JY, Chang HK, et al. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol. 2006;35(1):39.
   PubMed Web of Science ®Google Scholar
• Hiroshi F, Shomi O, Aya K, Kota S, Shoji S, Takashi M, et al. Human leukocyte antigen and systemic sclerosis in Japanese: the sign of the four independent protective alleles, DRB1*13:02,DRB1*14:06,DQB1*03:01, andDPB1*02:01. PLoS One 2016;11(4):e0154255.
   PubMed Web of Science ®Google Scholar
• Tikly M, Rands A, Mchugh N, Wordsworth P, Welsh K. Human leukocyte antigen class II associations with systemic sclerosis in South Africans. Tissue Antigens. 2004;63(5):487–90.
   PubMedGoogle Scholar
• Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, et al. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma. Association with an amerindian HLA haplotype. Arthritis Rheum. 1996;39(8):1362–70.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Inoko H, Kameda H, Nojima T, Sato S, Nakamura K, et al. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern Med. 1999;38(4):336.
   PubMed Web of Science ®Google Scholar
• Beretta L, Rueda B, Marchini M, Santaniello A, Simeón CP, Fonollosa V, et al. Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology 2012;51(1):52.
   PubMed Web of Science ®Google Scholar
• Vlachoyiannopoulos PG, Dafni UG, Pakas I, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Moutsopoulos HM. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. Ann Rheum Dis. 2000;59(5):359–67.
   PubMed Web of Science ®Google Scholar
• Simeón CP, Fonollosa V, Tolosa C, Palou E, Selva A, Solans R, et al. Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol. 2009;36(12):2733–6.
   PubMed Web of Science ®Google Scholar
• Salazar G, Mayes MD. Genetics, epigenetics and genomics of systemic sclerosis. Rheum Dis Clin North Am. 2015;41(3):345–66.
   PubMed Web of Science ®Google Scholar
• Dilia G, Federica L, Michele C, Poupak F, Alessandro A, Clodoveo F. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature. Autoimmun Rev. 2015;14(11):1072–8.
   PubMed Web of Science ®Google Scholar
• Bettencourt A, Carvalho C, Leal B, Brã sS, Lopes D, Martins dSA, et al. The protective role of HLA-DRB1(∗)13 in autoimmune diseases. J Immunol Res. 2015;2015(1):948723
   PubMed Web of Science ®Google Scholar
• Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheumatol. 1996;39(7):1151–60.
   Web of Science ®Google Scholar
• Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Human Immunol. 2003;64(10):930–5.
   PubMed Web of Science ®Google Scholar
• Hong X, Yu RB, Sun NX, Wang B, Xu YC, Wu GL. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. WJG. 2005;11(46):7302.
   PubMed Web of Science ®Google Scholar
• Pavoni DP, Roxo VMMS, Marquart Filho A, Petzl-Erler ML. Dissecting the associations of endemic pemphigus foliaceus (Fogo selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun. 2003;4(2):110.
   PubMed Web of Science ®Google Scholar
• Manan H, Angham AM, Sitelbanat A. Genetic and diabetic auto-antibody markers in Saudi children with type 1 diabetes. Hum Immunol. 2010;71(12):1238–42.
   PubMed Web of Science ®Google Scholar
• Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Ohnogi Y, et al. Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients. Rheumatol Int. 2013;33(8):2069–77.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Medsger TA, Wright TM. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J Immunol. 1995;155(5):2703–14.
   PubMed Web of Science ®Google Scholar
• Ta M. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. Arthritis & Allied Conditions. 1993;1253
   Google Scholar
• Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum. 1994;37(6):902–6.
   PubMed Web of Science ®Google Scholar
• Imanishi T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. Hla 1991;1:1065–1220
   Google Scholar
• Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010;69(5):822–7.
   PubMed Web of Science ®Google Scholar